20 results on '"Parche S"'
Search Results
2. Processing effects on the nutritional advancement of probiotics and prebiotics
- Author
-
Ananta, E., primary, Birkeland, S.-E., additional, Corcoran, B., additional, Fitzgerald, G., additional, Hinz, S., additional, Klijn, A., additional, Mättö, J., additional, Mercernier, A., additional, Nilsson, U., additional, Nyman, M., additional, O'Sullivan, E., additional, Parche, S., additional, Rautonen, N., additional, Ross, R.P., additional, Saarela, M., additional, Stanton, C., additional, Stahl, U., additional, Suomalainen, T., additional, Vincken, J.-P., additional, Virkajärvi, I., additional, Voragen, F., additional, Wesenfeld, J., additional, Wouters, R., additional, and Knorr, D., additional
- Published
- 2004
- Full Text
- View/download PDF
3. Stahlbetonstützen unter Erdbebenwirkung wechselnder Richtungen ‐ Simulation des Querschnittsverhaltens und der Schädigungsakkumulation (Teil 2).
- Author
-
Parche, S., primary
- Published
- 1997
- Full Text
- View/download PDF
4. Stahlbetonstützen unter Erdbebenwirkung wechselnder Richtungen ‐ Simulation des Querschnittsverhaltens und der Schädigungsakkumulation (Teil 1).
- Author
-
Parche, S., primary
- Published
- 1997
- Full Text
- View/download PDF
5. Identification and characterization of xcpR encoding a subunit of the general secretory pathway necessary for dodecane degradation in Acinetobacter calcoaceticus ADP1
- Author
-
Parche, S, primary, Geissdörfer, W, additional, and Hillen, W, additional
- Published
- 1997
- Full Text
- View/download PDF
6. A fibre model to simulate the cross-sectional behaviour of reinforced concrete columns under multi-directional earthquake loading
- Author
-
Parche, S.
- Published
- 2000
- Full Text
- View/download PDF
7. A More Realistic Seismic Safety Calculation of R/C Structures under Multi-Directional Earthquake Excitations
- Author
-
Parche, S., primary
- Full Text
- View/download PDF
8. RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a real-world lenalidomide monotherapy cohort in relapsed or refractory diffuse large B-cell lymphoma
- Author
-
Sumeet Ambarkhane, Mark Winderlich, Claudia Castellino, Sascha Tillmanns, Nathan Fowler, Erika Meli, Anna Maria Barbui, Nuwan C. Kurukulasuriya, Gilles Salles, Grzegorz S. Nowakowski, Maurizio Frezzato, Günter Fingerle-Rowson, Thomas D. Rodgers, Bruce Feinberg, Debarshi Dey, Pier Luigi Zinzani, Stephan Parche, Dario Marino, Zinzani P.L., Rodgers T., Marino D., Frezzato M., Barbui A.M., Castellino C., Meli E., Fowler N.H., Salles G., Feinberg B., Kurukulasuriya N.C., Tillmanns S., Parche S., Dey D., Fingerle-Rowson G., Ambarkhane S., Winderlich M., and Nowakowski G.S.
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Combination therapy ,Antibodies, Monoclonal, Humanized ,Retrospective Studie ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Clinical endpoint ,medicine ,Humans ,Refractory Diffuse Large B-Cell Lymphoma ,Lenalidomide ,Retrospective Studies ,Antineoplastic Combined Chemotherapy Protocol ,business.industry ,Retrospective cohort study ,Confidence interval ,Propensity score matching ,Cohort ,Lymphoma, Large B-Cell, Diffuse ,business ,medicine.drug ,Human - Abstract
Purpose: Tafasitamab, an Fc-modified, humanized, anti-CD19 monoclonal antibody, in combination with lenalidomide, demonstrated efficacy in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), in the single-arm, phase II L-MIND study (NCT02399085). RE-MIND, a retrospective observational study, generated a historic control for L-MIND to delineate the contribution of tafasitamab to the efficacy of the combination. Patients and Methods: Data were retrospectively collected from patients with R/R DLBCL treated with lenalidomide monotherapy for comparison with tafasitamab + lenalidomide–treated patients (L-MIND). Key eligibility criteria were aligned with L-MIND. Estimated propensity score–based Nearest Neighbor 1:1 Matching methodology balanced the cohorts for nine prespecified prognostic baseline covariates. The primary endpoint was investigator-assessed best overall response rate (ORR). Secondary endpoints included complete response (CR) rate, progression-free survival (PFS), and overall survival (OS). Results: Data from 490 patients going through lenalidomide monotherapy were collected; 140 qualified for matching with the L-MIND cohort. The primary analysis included 76 patients from each cohort who received a lenalidomide starting dose of 25 mg/day. Cohort baseline covariates were comparable. A significantly better ORR of 67.1% (95% confidence interval, 55.4–77.5) was observed for the combination therapy versus 34.2% (23.7–46.0) for lenalidomide monotherapy [odds ratio, 3.89 (1.90–8.14); P < 0.0001]. Higher CR rates were achieved with combination therapy compared with lenalidomide monotherapy [39.5% (28.4–51.4) vs. 13.2% (6.5–22.9)]. Survival endpoints favored combination therapy. Lenalidomide monotherapy outcomes were similar to previously published data. Conclusions: RE-MIND enabled the estimation of the additional treatment effect achieved by combining tafasitamab with lenalidomide in patients with R/R DLBCL.
- Published
- 2021
9. RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
- Author
-
Zinzani PL, Rodgers T, Marino D, Frezzato M, Barbui AM, Castellino C, Meli E, Fowler NH, Salles G, Feinberg B, Kurukulasuriya NC, Tillmanns S, Parche S, Dey D, Fingerle-Rowson G, Ambarkhane S, Winderlich M, and Nowakowski GS
- Subjects
- Antibodies, Monoclonal, Humanized, Humans, Lenalidomide, Retrospective Studies, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lymphoma, Large B-Cell, Diffuse drug therapy
- Abstract
Purpose: Tafasitamab, an Fc-modified, humanized, anti-CD19 monoclonal antibody, in combination with lenalidomide, demonstrated efficacy in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), in the single-arm, phase II L-MIND study (NCT02399085). RE-MIND, a retrospective observational study, generated a historic control for L-MIND to delineate the contribution of tafasitamab to the efficacy of the combination., Patients and Methods: Data were retrospectively collected from patients with R/R DLBCL treated with lenalidomide monotherapy for comparison with tafasitamab + lenalidomide-treated patients (L-MIND). Key eligibility criteria were aligned with L-MIND. Estimated propensity score-based Nearest Neighbor 1:1 Matching methodology balanced the cohorts for nine prespecified prognostic baseline covariates. The primary endpoint was investigator-assessed best overall response rate (ORR). Secondary endpoints included complete response (CR) rate, progression-free survival (PFS), and overall survival (OS)., Results: Data from 490 patients going through lenalidomide monotherapy were collected; 140 qualified for matching with the L-MIND cohort. The primary analysis included 76 patients from each cohort who received a lenalidomide starting dose of 25 mg/day. Cohort baseline covariates were comparable. A significantly better ORR of 67.1% (95% confidence interval, 55.4-77.5) was observed for the combination therapy versus 34.2% (23.7-46.0) for lenalidomide monotherapy [odds ratio, 3.89 (1.90-8.14); P < 0.0001]. Higher CR rates were achieved with combination therapy compared with lenalidomide monotherapy [39.5% (28.4-51.4) vs. 13.2% (6.5-22.9)]. Survival endpoints favored combination therapy. Lenalidomide monotherapy outcomes were similar to previously published data., Conclusions: RE-MIND enabled the estimation of the additional treatment effect achieved by combining tafasitamab with lenalidomide in patients with R/R DLBCL., (©2021 The Authors; Published by the American Association for Cancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
10. A genomic view of sugar transport in Mycobacterium smegmatis and Mycobacterium tuberculosis.
- Author
-
Titgemeyer F, Amon J, Parche S, Mahfoud M, Bail J, Schlicht M, Rehm N, Hillmann D, Stephan J, Walter B, Burkovski A, and Niederweis M
- Subjects
- Carbohydrates, Gene Expression Regulation, Bacterial, Mycobacterium smegmatis enzymology, Mycobacterium smegmatis physiology, Mycobacterium tuberculosis enzymology, Mycobacterium tuberculosis physiology, Biological Transport, Carbohydrate Metabolism, Membrane Transport Proteins metabolism, Mycobacterium smegmatis genetics, Mycobacterium tuberculosis genetics, Phosphoenolpyruvate Sugar Phosphotransferase System metabolism
- Abstract
We present a comprehensive analysis of carbohydrate uptake systems of the soil bacterium Mycobacterium smegmatis and the human pathogen Mycobacterium tuberculosis. Our results show that M. smegmatis has 28 putative carbohydrate transporters. The majority of sugar transport systems (19/28) in M. smegmatis belong to the ATP-binding cassette (ABC) transporter family. In contrast to previous reports, we identified genes encoding all components of the phosphotransferase system (PTS), including permeases for fructose, glucose, and dihydroxyacetone, in M. smegmatis. It is anticipated that the PTS of M. smegmatis plays an important role in the global control of carbon metabolism similar to those of other bacteria. M. smegmatis further possesses one putative glycerol facilitator of the major intrinsic protein family, four sugar permeases of the major facilitator superfamily, one of which was assigned as a glucose transporter, and one galactose permease of the sodium solute superfamily. Our predictions were validated by gene expression, growth, and sugar transport analyses. Strikingly, we detected only five sugar permeases in the slow-growing species M. tuberculosis, two of which occur in M. smegmatis. Genes for a PTS are missing in M. tuberculosis. Our analysis thus brings the diversity of carbohydrate uptake systems of fast- and a slow-growing mycobacteria to light, which reflects the lifestyles of M. smegmatis and M. tuberculosis in their natural habitats, the soil and the human body, respectively.
- Published
- 2007
- Full Text
- View/download PDF
11. Sugar transport systems of Bifidobacterium longum NCC2705.
- Author
-
Parche S, Amon J, Jankovic I, Rezzonico E, Beleut M, Barutçu H, Schendel I, Eddy MP, Burkovski A, Arigoni F, and Titgemeyer F
- Subjects
- Biological Transport, Gene Expression Regulation, Bacterial, Oligonucleotide Array Sequence Analysis, Oligosaccharides metabolism, Polysaccharides, Bacterial metabolism, Bifidobacterium metabolism, Carbohydrate Metabolism, Membrane Transport Proteins metabolism, Phosphotransferases metabolism
- Abstract
Here we present the complement of the carbohydrate uptake systems of the strictly anaerobic probiotic Bifidobacterium longum NCC2705. The genome analysis of this bacterium predicts that it has 19 permeases for the uptake of diverse carbohydrates. The majority belongs to the ATP-binding cassette transporter family with 13 systems identified. Among them are permeases for lactose, maltose, raffinose, and fructooligosaccharides, a commonly used prebiotic additive. We found genes that encode a complete phosphotransferase system (PTS) and genes for three permeases of the major facilitator superfamily. These systems could serve for the import of glucose, galactose, lactose, and sucrose. Growth analysis of NCC2705 cells combined with biochemical characterization and microarray data showed that the predicted substrates are consumed and that the corresponding transport and catabolic genes are expressed. Biochemical analysis of the PTS, in which proteins are central in regulation of carbon metabolism in many bacteria, revealed that B. longum has a glucose-specific PTS, while two other species (Bifidobacterium lactis and Bifidobacterium bifidum) have a fructose-6-phosphate-forming fructose-PTS instead. It became obvious that most carbohydrate systems are closely related to those from other actinomycetes, with a few exceptions. We hope that this report on B. longum carbohydrate transporter systems will serve as a guide for further in-depth analyses on the nutritional lifestyle of this beneficial bacterium., (Copyright (c) 2007 S. Karger AG, Basel.)
- Published
- 2007
- Full Text
- View/download PDF
12. Lactose-over-glucose preference in Bifidobacterium longum NCC2705: glcP, encoding a glucose transporter, is subject to lactose repression.
- Author
-
Parche S, Beleut M, Rezzonico E, Jacobs D, Arigoni F, Titgemeyer F, and Jankovic I
- Subjects
- Bacterial Proteins genetics, Base Sequence, Bifidobacterium growth & development, Biological Transport, Culture Media, DNA, Intergenic genetics, Gene Expression Regulation, Bacterial, Glucose Transport Proteins, Facilitative genetics, Molecular Sequence Data, Phosphoglucomutase genetics, Substrate Specificity, Transcription, Genetic, Bifidobacterium genetics, Bifidobacterium metabolism, Down-Regulation genetics, Genes, Bacterial, Glucose metabolism, Lactose physiology
- Abstract
Analysis of culture supernatants obtained from Bifidobacterium longum NCC2705 grown on glucose and lactose revealed that glucose utilization is impaired until depletion of lactose. Thus, unlike many other bacteria, B. longum preferentially uses lactose rather than glucose as the primary carbon source. Glucose uptake experiments with B. longum cells showed that glucose transport was repressed in the presence of lactose. A comparative analysis of global gene expression profiling using DNA arrays led to the identification of only one gene repressed by lactose, the putative glucose transporter gene glcP. The functionality of GlcP as glucose transporter was demonstrated by heterologous complementation of a glucose transport-deficient Escherichia coli strain. Additionally, GlcP exhibited the highest substrate specificity for glucose. Primer extension and real-time PCR analyses confirmed that expression of glcP was mediated by lactose. Hence, our data demonstrate that the presence of lactose in culture medium leads to the repression of glucose transport and transcriptional down-regulation of the glucose transporter gene glcP. This may reflect the highly adapted life-style of B. longum in the gastrointestinal tract of mammals.
- Published
- 2006
- Full Text
- View/download PDF
13. Rapid identification of stress-related fingerprint from whole bacterial cells of Bifidobacterium lactis using matrix assisted laser desorption/ionization mass spectrometry.
- Author
-
Marvin-Guy LF, Parche S, Wagnière S, Moulin J, Zink R, Kussmann M, and Fay LB
- Subjects
- Bifidobacterium drug effects, Bifidobacterium metabolism, Bile Acids and Salts pharmacology, Dose-Response Relationship, Drug, Reproducibility of Results, Bifidobacterium cytology, Peptide Mapping, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Abstract
Whole cells of Bifidobacterium lactis were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS). Characteristic and reproducible mass spectra were obtained in the mass range from 6 to 19 kDa. After several days of bacterial cell storage at 4 degrees C (D0, D2, and D6), only minor signal differences were observed. Under identical and reproducible conditions, fourteen relevant diagnostic ions were identified. Moreover, control- and stress-related fingerprints were rapidly obtained using MALDI-TOFMS by comparison of protein patterns obtained from non-stressed (control) versus stressed cells (addition of bile salts during growth). After quantitative validation of the MALDI-MS data by a statistical approach, two and eight signals were assigned as control- and stress-specific ions, respectively. This work provides the evidence that MALDI-TOFMS can be used for the identification of stress-related fingerprint of B. lactis bacterial cells and could have a high potential for the assessment of the physiological status of the cells.
- Published
- 2004
- Full Text
- View/download PDF
14. The histidine-phosphocarrier protein of Streptomyces coelicolor folds by a partially folded species at low pH.
- Author
-
Fernández-Ballester G, Maya J, Martín A, Parche S, Gómez J, Titgemeyer F, and Neira JL
- Subjects
- Amino Acid Sequence, Anilino Naphthalenesulfonates pharmacology, Calorimetry, Differential Scanning, Chromatography, Gel, Circular Dichroism, Dose-Response Relationship, Drug, Hydrogen-Ion Concentration, Kinetics, Molecular Sequence Data, Protein Conformation, Protein Folding, Sequence Homology, Amino Acid, Spectrometry, Fluorescence, Spectroscopy, Fourier Transform Infrared, Temperature, Thermodynamics, Ultraviolet Rays, Bacterial Proteins, Phosphoenolpyruvate Sugar Phosphotransferase System chemistry, Streptomyces metabolism
- Abstract
The folding of a 93-residue protein, the histidine-phosphocarrier protein of Streptomyces coelicolor, HPr, has been studied using several biophysical techniques, namely fluorescence, 8-anilinonaphthalene-1-sulfate binding, circular dichroism, Fourier transform infrared spectroscopy, gel filtration chromatography and differential scanning calorimetry. The chemical-denaturation behaviour of HPr, followed by fluorescence, CD and gel filtration, at pH 7.5 and 25 degrees C, is described as a two-state process, which does not involve the accumulation of thermodynamically stable intermediates. Its conformational stability under those conditions is deltaG = 4.0 +/- 0.2 kcal x mol-1 (1 kcal = 4.18 kJ), which makes the HPr from S. coelicolor the most unstable member of the HPr family described so far. The stability of the protein does not change significantly from pH 7-9, as concluded from the differential scanning calorimetry and thermal CD experiments. Conformational studies at low pH (pH 2.5-4) suggest that, in the absence of cosmotropic agents, HPr does not unfold completely; rather, it accumulates partially folded species. The transition from those species to other states with native-like secondary and tertiary structure, occurs with a pKa = 3.3 +/- 0.3, as measured by the averaged measurements obtained by CD and fluorescence. However, this transition does not agree either with: (a) that measured by burial of hydrophobic patches (8-anilinonaphthalene-1-sulfate binding experiments); or (b) that measured by acquisition of native-like compactness (gel-filtration studies). It seems that acquisition of native-like features occurs in a wide pH range and it cannot be ascribed to a unique side-chain titration. These series of intermediates have not been reported previously in any member of the HPr family.
- Published
- 2003
- Full Text
- View/download PDF
15. In vivo analysis of HPr reveals a fructose-specific phosphotransferase system that confers high-affinity uptake in Streptomyces coelicolor.
- Author
-
Nothaft H, Parche S, Kamionka A, and Titgemeyer F
- Subjects
- Amino Acid Sequence, Base Sequence, Carbon metabolism, Codon, Molecular Sequence Data, Phosphoenolpyruvate Sugar Phosphotransferase System genetics, Bacterial Proteins, Fructose metabolism, Phosphoenolpyruvate Sugar Phosphotransferase System physiology, Streptomyces metabolism
- Abstract
HPr, the histidine-containing phosphocarrier protein of the bacterial phosphotransferase system (PTS), serves multiple functions in carbohydrate uptake and carbon source regulation in low-G+C-content gram-positive bacteria and in gram-negative bacteria. To assess the role of HPr in the high-G+C-content gram-positive organism Streptomyces coelicolor, the encoding gene, ptsH, was deleted. The ptsH mutant BAP1 was impaired in fructose utilization, while growth on other carbon sources was not affected. Uptake assays revealed that BAP1 could not transport appreciable amounts of fructose, while the wild type showed inducible high-affinity fructose transport with an apparent K(m) of 2 microM. Complementation and reconstitution experiments demonstrated that HPr is indispensable for a fructose-specific PTS activity. Investigation of the putative fruKA gene locus led to identification of the fructose-specific enzyme II permease encoded by the fruA gene. Synthesis of HPr was not specifically enhanced in fructose-grown cells and occurred also in the presence of non-PTS carbon sources. Transcriptional analysis of ptsH revealed two promoters that are carbon source regulated. In contrast to what happens in other bacteria, glucose repression of glycerol kinase was still operative in a ptsH background, which suggests that HPr is not involved in general carbon regulation. However, fructose repression of glycerol kinase was lost in BAP1, indicating that the fructose-PTS is required for transduction of the signal. This study provides the first molecular genetic evidence of a physiological role of the PTS in S. coelicolor.
- Published
- 2003
- Full Text
- View/download PDF
16. The phosphotransferase system of Streptomyces coelicolor.
- Author
-
Kamionka A, Parche S, Nothaft H, Siepelmeyer J, Jahreis K, and Titgemeyer F
- Subjects
- Amino Acid Sequence, Biological Transport, Escherichia coli enzymology, Escherichia coli Proteins, Molecular Sequence Data, Phosphoenolpyruvate Sugar Phosphotransferase System genetics, Phosphotransferases genetics, Sequence Analysis, DNA, Phosphoenolpyruvate Sugar Phosphotransferase System metabolism, Phosphotransferases metabolism, Streptomyces enzymology
- Abstract
We have investigated the crr gene of Streptomyces coelicolor that encodes a homologue of enzyme IIAGlucose of Escherichia coli, which, as a component of the phosphoenolpyruvate-dependent sugar phosphotransferase system (PTS) plays a key role in carbon regulation by triggering glucose transport, carbon catabolite repression, and inducer exclusion. As in E. coli, the crr gene of S. coelicolor is genetically associated with the ptsI gene that encodes the general phosphotransferase enzyme I. The gene product IIACrr was overproduced, purified, and polyclonal antibodies were obtained. Western blot analysis revealed that IIACrr is expressed in vivo. The functionality of IIACrr was demonstrated by phosphoenolpyruvate-dependent phosphorylation via enzyme I and the histidine-containing phosphoryl carrier protein HPr. Phosphorylation was abolished when His72, which corresponds to the catalytic histidine of E. coli IIAGlucose, was mutated. The capacity of IIACrr to operate in sugar transport was shown by complementation of the E. coli glucose-PTS. The striking functional resemblance between IIACrr and IIAGlucose was further demonstrated by its ability to confer inducer exclusion of maltose to E. coli. A specific interaction of IIACrr with the maltose permease subunit MalK from Salmonella typhimurium was uncovered by surface plasmon resonance. These data suggest that this IIAGlucose-like protein may be involved in carbon metabolism in S. coelicolor.
- Published
- 2002
- Full Text
- View/download PDF
17. Corynebacterium diphtheriae: a PTS view to the genome.
- Author
-
Parche S, Thomae AW, Schlicht M, and Titgemeyer F
- Subjects
- Base Sequence, Chromosome Mapping, Consensus Sequence, Molecular Sequence Data, Phosphoenolpyruvate Sugar Phosphotransferase System metabolism, Bacterial Proteins, Corynebacterium diphtheriae enzymology, Corynebacterium diphtheriae genetics, Genome, Bacterial, Phosphoenolpyruvate Sugar Phosphotransferase System genetics
- Abstract
We have surveyed the publicly available genome sequence of Corynebacterium diphtheriae (www.sanger.ac.uk) to identify components of the phosphotransferase system (PTS), which plays a central role in carbon metabolism in many bacteria. Three gene loci were found to contain putative pts genes. These comprise: (i) the genes of the general phosphotransferases enzyme I (ptsI) and HPr (ptsH), a fructose-specific enzyme IIABC permease (fruA), and a fructose 1-phosphate kinase (fruK); (ii) a gene that encodes an enzyme IIAB of the fructose/mannitol family, and a novel HPr-like gene, ptsF, that encodes an HPr domain fused to a domain of unknown function; (iii) and a gene for a glucose-specific enzyme IIBCA (ptsG). A search for genes that may be putative PTS-targets or that may operate in general carbon regulation revealed a possible regulatory gene encoding an antiterminator protein downstream from ptsG. Furthermore, genes were detected encoding glycerol kinase, glucose kinase, and a homologue of the global activator of carbon catabolite repression in Escherichia coli, CAP. The possible significance of these observations in carbon metabolism and the novel features of the detected genes are discussed.
- Published
- 2001
18. Corynebacterium glutamicum: a dissection of the PTS.
- Author
-
Parche S, Burkovski A, Sprenger GA, Weil B, Krämer R, and Titgemeyer F
- Subjects
- Animal Feed, Animals, Corynebacterium genetics, Fructose metabolism, Glucose metabolism, Mutagenesis, Phenotype, Bacterial Proteins, Corynebacterium enzymology, Phosphoenolpyruvate Sugar Phosphotransferase System genetics, Phosphoenolpyruvate Sugar Phosphotransferase System metabolism
- Abstract
The high-GC Gram-positive actinomycete Corynebacterium glutamicum is commercially exploited as a producer of amino acids that are used as animal feed additives and flavor enhancers. Despite its beneficial role, carbon metabolism and its possible influence on amino acid metabolism is poorly understood. We have addressed this issue by analyzing the phosphotransferase system (PTS), which in many bacteria controls the flux of nutrients and therefore regulates carbon metabolism. The general PTS phosphotransferases enzyme I (EI) and HPr were characterized by demonstration of PEP-dependent phosphotransferase activity. An EI mutant exhibited a pleiotropic negative phenotype in carbon utilization. The role of the PTS as a major sugar uptake system was further demonstrated by the finding that glucose and fructose negative mutants were deficient in the respective enzyme II PTS permease activities. These carbon sources also caused repression of glutamate uptake, which suggests an involvement of the PTS in carbon regulation. The observation that no HPr kinase/phosphatase could be detected suggests that the mechanism of carbon regulation in C. glutamicum is different to the one found in low-GC Gram-positive bacteria.
- Published
- 2001
19. Sugar uptake and utilisation in Streptomyces coelicolor: a PTS view to the genome.
- Author
-
Parche S, Nothaft H, Kamionka A, and Titgemeyer F
- Subjects
- Amino Acid Sequence, Bacteria classification, Bacteria genetics, Biological Transport, Consensus Sequence, Escherichia coli Proteins, Genetic Complementation Test, Molecular Sequence Data, Phosphoenolpyruvate Sugar Phosphotransferase System chemistry, Phosphoenolpyruvate Sugar Phosphotransferase System metabolism, Phosphotransferases (Nitrogenous Group Acceptor) genetics, Plasmids, Polymerase Chain Reaction, Restriction Mapping, Sequence Alignment, Sequence Homology, Amino Acid, Software, Streptomyces enzymology, Bacterial Proteins, Evolution, Molecular, Genome, Bacterial, Phosphoenolpyruvate Sugar Phosphotransferase System genetics, Phylogeny, Streptomyces genetics, Streptomyces metabolism
- Abstract
Our research group is studying the phosphotransferase system (PTS) of Streptomyces coelicolor, which, in other bacteria, is centrally involved in carbon source uptake and regulation. We have surveyed the public available S. coelicolor genome sequence produced by the ongoing genome sequencing project for pts gene homologues (http://www.sanger.ac.uk/Projects/S_coelicolor/). Three genes encoding homologues of the general PTS components enzyme I (ptsI), HPr (ptsH), and enzyme IIA(Crr) (crr; IIA(Glc)-homologue) and six genes encoding homologues of sugar-specific PTS components were identified. The deduced primary sequences of the sugar-specific components shared significant similarities to PTS permeases of the mannitol/fructose family and of the glucose/sucrose family. A model is presented, in which possible functions of the novel described PTS homologues are discussed.
- Published
- 2000
- Full Text
- View/download PDF
20. The phosphotransferase system (PTS) of Streptomyces coelicolor identification and biochemical analysis of a histidine phosphocarrier protein HPr encoded by the gene ptsH.
- Author
-
Parche S, Schmid R, and Titgemeyer F
- Subjects
- Adenosine Triphosphate metabolism, Amino Acid Sequence, Bacillus subtilis genetics, Cloning, Molecular, Consensus Sequence, Escherichia coli, Escherichia coli Proteins, Evolution, Molecular, Genetic Complementation Test, Molecular Sequence Data, Monosaccharide Transport Proteins, Peptide Fragments chemistry, Phosphoenolpyruvate Sugar Phosphotransferase System classification, Phosphoenolpyruvate Sugar Phosphotransferase System metabolism, Phosphorylation, Phosphotransferases (Nitrogenous Group Acceptor) metabolism, Phylogeny, Protein Serine-Threonine Kinases metabolism, Recombinant Proteins metabolism, Sequence Analysis, Protein, Sequence Homology, Amino Acid, Staphylococcus aureus genetics, Bacterial Proteins, Genes, Bacterial, Phosphoenolpyruvate Sugar Phosphotransferase System genetics, Streptomyces genetics
- Abstract
HPr, the histidine-containing phosphocarrier protein of the bacterial phosphotransferase system (PTS) controls sugar uptake and carbon utilization in low-GC Gram-positive bacteria and in Gram-negative bacteria. We have purified HPr from Streptomyces coelicolor cell extracts. The N-terminal sequence matched the product of an S. coelicolor orf, designated ptsH, sequenced as part of the S. coelicolor genome sequencing project. The ptsH gene appears to form a monocistronic operon. Determination of the evolutionary relationship revealed that S. coelicolor HPr is equally distant to all known HPr and HPr-like proteins. The presumptive phosphorylation site around histidine 15 is perfectly conserved while a second possible phosphorylation site at serine 47 is not well-conserved. HPr was overproduced in Escherichia coli in its native form and as a histidine-tagged fusion protein. Histidine-tagged HPr was purified to homogeneity. HPr was phosphorylated by its own enzyme I (EI) and heterologously phosphorylated by EI of Bacillus subtilis and Staphylococcus aureus, respectively. This phosphoenolpyruvate-dependent phosphorylation was absent in an HPr mutant in which histidine 15 was replaced by alanine. Reconstitution of the fructose-specific PTS demonstrated that HPr could efficiently phosphorylate enzyme IIFructose. HPr-P could also phosphorylate enzyme IIGlucose of B. subtilis, enzyme IILactose of S. aureus, and IIAMannitol of E. coli. ATP-dependent phosphorylation was detected with HPr kinase/phosphatase of B. subtilis. These results present the first identification of a gene of the PTS complement of S. coelicolor, providing the basis to elucidate the role(s) of HPr and the PTS in this class of bacteria.
- Published
- 1999
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.